The Company has executed a binding business combination agreement for the purchase of Biogenysis, Inc. ("BGEN") and Virogentics Inc. ("VIRO"), operating subsidiaries of Enzolytics Inc. (OTC PK: ENZC). The combined company is expected to trade on NASDAQ. Have fun doing your due diligence. See you Monday 😏 https://www.otcmarkets.com/stock/ENZC/news/SAGALIAM-ACQUISITION-CORP-ANNOUNCES-EXECUTION-OF-DEFINITIVE-BUSINESS-COMBINATION-AGREEMENT-AND-RECEIPT-OF-NASDAQ-LISTING?id=414357 https://www.sec.gov/Archives/edgar/data/1855351/000149315223032803/ex99-2.htm @sirjack